semaglutide & tirzepatide stafford Comparative effectiveness of versus liraglutide, dulaglutide or tirzepatide: a systematic review and meta-analysis Semaglutide, tirzepatide recommended as first-line

In general, these medications are used for people with obesity, or for people who are overweight and also dealing with related conditions like obstructive sleep apnea, hypertension, or other metabolic concerns

Safety-focused summary of GLP-1 receptor agonists in diabetes, obesity, and beyond

Both options require ongoing medical supervision and lifestyle changes to maintain results safely

Another key driver is the diversification of therapeutic area, i.e., obesity and management of cardio metabolic risk to expand market opportunity

These approaches reduce risk while still supporting effective diabetes and weight management